Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Lars-Erik T. Eriksson

Market Cap

70.99 Million SEK

Sector

Healthcare

Website

https://www.clinicallaser.se

Description

Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden.

Read More

Overview

Value

1

Growth

39

Health

13

Management

50

Analyst Opinion

60

Total

33

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • 0
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor overall financial health
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth
  • 0

Market Peers

CLS-B.ST

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-129.89%

Revenue Growth (5 Year Average)

24.72%

Ratings Consensus

Neutral

Share Buybacks

-8.50%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined SEK is lower than current price ( 368.00 undefined SEK)
  • Free-cashflow-yeild of -24.24% is worse than the market average (4.7%)
  • Margin-of-safety of -129.89% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0.4 SEK

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-24.24%

PE/Earnings Growth

N/A

Price/Book

3.27x

Growth

Growth Score

39

  • 5 Year Average Revenue growth of 24.72% is higher than the market average (10.97%)
  • Earnings growth has improved this year
  • Free Cashflow growth has improved this year
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of -3.02% is lower than the market average (14.48%)
  • 5 Year Average Free Cashflow growth of 0.01% is lower than the market average (12.35%)

Revenue Growth

24.72%

Earnings Growth

-3.02%

Cashflow Growth

0.01%

Health

Health Score

13

  • Has a low level of debt
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • 0
  • Assets do not cover liabilities
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

2.00

Debt/Equity

N/Ax

Current Assets/Liabilities

0.61x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

N/Ax

Management

Management Score

50

  • Has issued new shares to finance growth when share price is high
  • Return-on-capital-employed of -22.92% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of -226.88% is lower than the market average (15%)

Average Buybacks/Dilution

-8.50%

Recent Buybacks/Dilution

54.64%

5 Year Price Volitility

51.93%

Return On Assets

-77.79%

Return On Capital Employed

-22.92%

Return On Equity

-226.88%

Return On Free Cashflow

N/A

Return On Investments

-31005.16%

Analysts

Analyst Opinion

60

  • Ratings consensus is Neutral

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Clinical Laserthermia Systems AB (publ)

Currency

SEK

Beta

0.878039

Vol Avg

511462

Ceo

Mr. Lars-Erik T. Eriksson

Cik

Cusip

Exchange

Stockholm Stock Exchange

Full Time Employees

12

Industry

Medical Devices

Sector

Healthcare

Ipo Date

2009-04-16

Address

Building 405

City

Lund

State

Country

SE

Zip

223 81

Phone

46 46 15 21 00

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies